Quarterly Results

  • Company Name :
Lincoln Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 531633
  • NSE Symbol:
  • LINCOLN
  • P/E(TTM):
  • 13.60
  • ISIN Demat:
  • INE405C01035
  • Div & Yield%:
  • 0.32
  • EPS(TTM):
  • 41.11
  • Book Value(₹):
  • 335.34
  • Market Cap(₹Cr.):
  • 1,120.16
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 168.18 146.55 161.21
Excise Duty 0.00 0.00 0.00
Net Sales 168.18 146.55 161.21
Other Operating Income 0.00 0.00 0.00
Other Income -6.88 8.97 9.98
Total Income 161.30 155.52 171.19
Total Expenditure 141.46 122.89 132.83
PBIDT 19.84 32.63 38.36
Interest 0.37 0.73 0.35
PBDT 19.47 31.91 38.01
Depreciation 3.23 3.22 3.22
Tax 6.65 8.05 5.12
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -1.98 -0.13 3.33
Reported Profit After Tax 11.58 20.77 26.33
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 11.58 20.77 26.33
EPS (Unit Curr.) 5.78 10.37 13.15
EPS (Adj) (Unit Curr.) 5.78 10.37 13.15
Calculated EPS (Unit Curr.) 5.78 10.37 13.15
Calculated EPS (Adj) (Unit Curr.) 5.78 10.37 13.15
Calculated EPS (Ann.) (Unit Curr.) 23.12 41.48 52.58
Calculated EPS (Adj) (Ann.) (Unit Curr.) 23.12 41.48 52.58
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 20.03 20.03 20.03
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 11.80 22.27 23.80
PBDTM(%) 11.58 21.77 23.58
PATM(%) 6.89 14.17 16.33